AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2021
Apr 16, 2021
32939_dirs_2021-04-16_adb1da6d-0c4c-4898-88e6-bb5174018fb6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2021-04-15
Reporting Person: Trowbridge Stephen A (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-15 | Common Stock | M | 13625 | $14.07 | Acquired | 73371 | Direct |
| 2021-04-15 | Common Stock | F | 10080 | $24.21 | Disposed | 63291 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-15 | Non-Qualified Stock Option (right to buy) | $14.07 | M | 13625 | Disposed | 2021-07-25 | Common Stock (13625) | Direct |
Footnotes
F1: The disposition of 10,080 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. reflects a net exercise of options expiring on July 25, 2021, in which shares of Common Stock were disposed to satisfy the payment of the exercise price and tax withholding obligations.
F2: Options for one-fourth of the shares became exercisable on 7/25/2015, 7/25/2016, 7/25/2017 and 7/25/2018, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6